July 2, 2018 / 5:41 PM / 4 months ago

BRIEF-Adamis Pharmaceuticals Says Unless Earlier Terminated, Deal With Sandoz Will Expire 10 Yrs From Launch Of Product

July 2 (Reuters) - Adamis Pharmaceuticals Corp:

* ADAMIS PHARMACEUTICALS - DEAL WITH SANDOZ FOR SYMJEPI PROVIDES SANDOZ WILL PAY TO CO 50% OF NET PROFIT FROM NET SALES OF PRODUCT

* ADAMIS PHARMACEUTICALS - UNLESS EARLIER TERMINATED, DEAL WITH SANDOZ WILL EXPIRE 10 YRS FROM LAUNCH OF PRODUCT, WITH ANNUAL RENEWAL TERMS THEREAFTER Source text: (bit.ly/2tOL8Kz) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below